Randomised placebo-controlled trials of surgery: ethical analysis and guidelines

Use of a placebo control in surgical trials is a divisive issue. We argue that, in principle, placebo controls for surgery are necessary in the same way as for medicine. However, there are important differences between these types of trial, which both increase justification and limit application of...

Full description

Saved in:  
Bibliographic Details
Authors: Savulescu, Julian (Author) ; Wartolowska, Karolina (Author) ; Carr, Andy (Author)
Format: Electronic Article
Language:English
Check availability: HBZ Gateway
Journals Online & Print:
Drawer...
Fernleihe:Fernleihe für die Fachinformationsdienste
Published: BMJ Publ. 2016
In: Journal of medical ethics
Year: 2016, Volume: 42, Issue: 12, Pages: 776-783
Online Access: Volltext (JSTOR)
Volltext (kostenfrei)
Volltext (kostenfrei)

MARC

LEADER 00000caa a22000002 4500
001 1816154644
003 DE-627
005 20230426115850.0
007 cr uuu---uuuuu
008 220908s2016 xx |||||o 00| ||eng c
024 7 |a 10.1136/medethics-2015-103333  |2 doi 
035 |a (DE-627)1816154644 
035 |a (DE-599)KXP1816154644 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 1  |2 ssgn 
100 1 |a Savulescu, Julian  |e VerfasserIn  |4 aut 
245 1 0 |a Randomised placebo-controlled trials of surgery: ethical analysis and guidelines 
264 1 |c 2016 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
520 |a Use of a placebo control in surgical trials is a divisive issue. We argue that, in principle, placebo controls for surgery are necessary in the same way as for medicine. However, there are important differences between these types of trial, which both increase justification and limit application of surgical studies. We propose that surgical randomised placebo-controlled trials are ethical if certain conditions are fulfilled: (1) the presence of equipoise, defined as a lack of unbiased evidence for efficacy of an intervention; (2) clinically important research question; (3) the risk to patients is minimised and reasonable; (4) there is uncertainty about treatment allocation rather than deception; (5) there is preliminary evidence for efficacy, which justifies a placebo-controlled design; and (6) ideally, the placebo procedure should have some direct benefit to the patient, for example, as a diagnostic tool. Placebo-controlled trials in surgery will most often be justified when surgery is performed to improve function or relieve symptoms and when objective outcomes are not available, while the risk of mortality or significant morbidity is low. In line with medical placebo-controlled trials, the surgical trial (1) should be sufficiently powered and (2) standardised so that its results are valid, (3) consent should be valid, (4) the standard treatment or rescue medication should be provided if possible, and (5) after the trial, the patients should be told which treatment they received and there should be provision for post-trial care if the study may result in long-term negative effects. We comment and contrast our guidelines with those of the American Medical Association. 
700 1 |a Wartolowska, Karolina  |e VerfasserIn  |4 aut 
700 1 |a Carr, Andy  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Journal of medical ethics  |d London : BMJ Publ., 1975  |g 42(2016), 12, Seite 776-783  |h Online-Ressource  |w (DE-627)323607802  |w (DE-600)2026397-1  |w (DE-576)260773972  |x 1473-4257  |7 nnns 
773 1 8 |g volume:42  |g year:2016  |g number:12  |g pages:776-783 
856 |3 Volltext  |u http://www.jstor.org/stable/44606012  |x JSTOR 
856 |u https://jme.bmj.com/content/medethics/42/12/776.full.pdf  |x unpaywall  |z Vermutlich kostenfreier Zugang  |h publisher [open (via page says license)] 
856 4 0 |u https://doi.org/10.1136/medethics-2015-103333  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u http://jme.bmj.com/content/42/12/776.abstract  |x Verlag  |z kostenfrei  |3 Volltext 
935 |a mteo 
951 |a AR 
ELC |a 1 
ITA |a 1  |t 1 
LOK |0 000 xxxxxcx a22 zn 4500 
LOK |0 001 4185608586 
LOK |0 003 DE-627 
LOK |0 004 1816154644 
LOK |0 005 20220908053703 
LOK |0 008 220908||||||||||||||||ger||||||| 
LOK |0 035   |a (DE-Tue135)IxTheo#2022-08-03#A76758016F2F352DC36B4118ECF4584BA93AA422 
LOK |0 040   |a DE-Tue135  |c DE-627  |d DE-Tue135 
LOK |0 092   |o n 
LOK |0 852   |a DE-Tue135 
LOK |0 852 1  |9 00 
LOK |0 866   |x JSTOR#http://www.jstor.org/stable/44606012 
LOK |0 935   |a ixzs  |a ixrk  |a zota 
OAS |a 1 
ORI |a SA-MARC-ixtheoa001.raw